Biomarkers Take Center Stage | GenomeWeb

Biomarkers Take Center Stage


It often seems that nearly everyone is on the search for a biomarker, whether it is for Alzheimer's disease, diabetes, certain types of cancer, or schizophrenia. The search, however, isn't always easy and can be fraught with challenges. At the end of this past May, Genome Technology invited Cornell University's Fabien Campagne and the University of Medicine and Dentistry of New Jersey's Scott Diehl to come to the GT office to speak with Ciara Curtin about the difficulties facing biomarker research. What follows are excerpts of that conversation.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.